Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Argos Therapeutics Inc (NASDAQ:ARGS)

4.13
Delayed Data
As of Feb 12
 +0.17 / +4.29%
Today’s Change
1.61
Today|||52-Week Range
9.64
+78.79%
Year-to-Date

Today’s Trading

Previous close3.96
Today’s open3.90
Day’s range3.81 - 4.29
Volume94,762
Average volume (3 months)96,684
Market cap$85.6M
Dividend yield--
Data as of 4:00pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)+87.30%
Earnings growth (this year)-12.71%
Earnings growth (next 5 years)--
Revenue growth (last year)-55.36%
P/E ratioNM
Price/Sales87.98
Price/Book2.59

Competitors

 Today’s
change
Today’s
% change
JNPJuniper Pharmaceutic...+0.56+7.71%
PVCTProvectus Biopharmac...-0.03-6.48%
CLCDCoLucid Pharmaceutic...-0.01-0.18%
--EcoGreen Internation...0.000.00%
Data as of 4:00pm ET, 02/12/2016

Financials

Next reporting dateMarch 24, 2016
EPS forecast (this quarter)-$0.86
Annual revenue (last year)$2.0M
Annual profit (last year)-$53.3M
Net profit margin-2,700.38%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Jeffrey D. Abbey
Chief Operating Officer &
VP-Manufacturing
Frederick M. Miesowicz
Corporate headquarters
Durham, North Carolina

Forecasts

Partner Offers